Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.
2.

Outsmarted by nootropics? An investigation into the thermal degradation of modafinil, modafinic acid, adrafinil, CRL-40,940 and CRL-40,941 in the GC injector: formation of 1,1,2,2-tetraphenylethane and its tetra fluoro analog.

Dowling G, Kavanagh PV, Talbot B, O'Brien J, Hessman G, McLaughlin G, Twamley B, Brandt SD.

Drug Test Anal. 2017 Mar;9(3):518-528. doi: 10.1002/dta.2142. Epub 2016 Dec 29.

PMID:
27928893
3.

Fluorescent zinc and copper complexes for detection of adrafinil in paper-based microfluidic devices.

Caglayan MG, Sheykhi S, Mosca L, Anzenbacher P.

Chem Commun (Camb). 2016 Jul 7;52(53):8279-82. doi: 10.1039/c6cc03640f. Epub 2016 Jun 13.

PMID:
27293080
4.

Cardiovascular stimulant actions of bupropion in comparison to cocaine in the rat.

Killian LM, Docherty JR.

Eur J Pharmacol. 2014 Jul 15;735:32-7. doi: 10.1016/j.ejphar.2014.03.059. Epub 2014 Apr 19.

PMID:
24755144
5.

Prevalence of legal and illegal stimulating agents in sports.

Deventer K, Roels K, Delbeke FT, Van Eenoo P.

Anal Bioanal Chem. 2011 Aug;401(2):421-32. doi: 10.1007/s00216-011-4863-0. Epub 2011 Apr 9. Review.

PMID:
21479548
7.

A novel study of screening and confirmation of modafinil, adrafinil and their metabolite modafinilic acid under EI-GC-MS and ESI-LC-MS-MS ionization.

Dubey S, Ahi S, Reddy IM, Kaur T, Beotra A, Jain S.

Indian J Pharmacol. 2009 Dec;41(6):278-83. doi: 10.4103/0253-7613.59928.

8.

LC-MS of novel narcoepileptics and related substances.

Rao RN, Shinde DD, Ramesh V, Srinivas R.

J Sep Sci. 2009 May;32(9):1312-22. doi: 10.1002/jssc.200800647.

PMID:
19399862
9.

Doping control analysis for adrafinil and its major metabolites in human urine.

Lu J, Wang X, Yang S, Liu X, Qin Y, Shen L, Wu Y, Xu Y, Wu M, Ouyang G.

Rapid Commun Mass Spectrom. 2009 Jun;23(11):1592-600. doi: 10.1002/rcm.4044.

PMID:
19399790
11.

LC-ESI-MS determination and pharmacokinetics of adrafinil in rats.

Rao RN, Shinde DD, Talluri MV, Agawane SB.

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Sep 15;873(1):119-23. doi: 10.1016/j.jchromb.2008.07.025. Epub 2008 Jul 29.

PMID:
18723408
12.
13.

Effect of noradrenergic system on the anxiolytic-like effect of DOI (5-HT2A/2C agonists) in the four-plate test.

Massé F, Hascoët M, Dailly E, Bourin M.

Psychopharmacology (Berl). 2006 Jan;183(4):471-81. Epub 2005 Nov 24.

PMID:
16307296
14.

The canine model of human cognitive aging and dementia: pharmacological validity of the model for assessment of human cognitive-enhancing drugs.

Studzinski CM, Araujo JA, Milgram NW.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Mar;29(3):489-98. Review.

PMID:
15795058
15.

Adrafinil-induced orofacial dyskinesia.

Thobois S, Xie J, Mollion H, Benatru I, Broussolle E.

Mov Disord. 2004 Aug;19(8):965-6.

PMID:
15300665
16.

Adrafinil disrupts performance on a delayed nonmatching-to-position task in aged beagle dogs.

Siwak CT, Tapp PD, Milgram NW.

Pharmacol Biochem Behav. 2003 Aug;76(1):161-8.

PMID:
13679229
17.

Adrafinil: effects on behavior and cognition in aged canines.

Siwak CT, Callahan H, Milgram NW.

Prog Neuropsychopharmacol Biol Psychiatry. 2000 Jul;24(5):709-26.

PMID:
11191710
18.

Comparison of the effects of adrafinil, propentofylline, and nicergoline on behavior in aged dogs.

Siwak CT, Gruet P, Woehrlé F, Muggenburg BA, Murphey HL, Milgram NW.

Am J Vet Res. 2000 Nov;61(11):1410-4.

PMID:
11108188
19.

Oral administration of adrafinil improves discrimination learning in aged beagle dogs.

Milgram NW, Siwak CT, Gruet P, Atkinson P, Woehrlé F, Callahan H.

Pharmacol Biochem Behav. 2000 Jun;66(2):301-5.

PMID:
10880682
20.

Behavioral activating effects of adrafinil in aged canines.

Siwak CT, Gruet P, Woehrlé F, Schneider M, Muggenburg BA, Murphey HL, Callahan H, Milgram NW.

Pharmacol Biochem Behav. 2000 Jun;66(2):293-300.

PMID:
10880681

Supplemental Content

Loading ...
Support Center